Search

For patients with some hard-to-treat blood cancers, a new immunotherapy is achieving promising results. A clinical trial of the developmental drug Glofitamab has shown it can produce a durable “complete response” –... Read more

Associate Professor Paul Neeson and his team have been exploring how, through immunotherapy, they can use a combination of drugs to stimulate the immune system and boost the body’s own defences against blood cancers, like... Read more

There’s now new hope for treating many types of tumours where chemotherapy has been ineffective. Nuclear medicine, which uses radioactive tracers to help clinicians better identify cancer tumours and monitor the spread of... Read more

Like so many of us, Rosemary is no stranger to the effects of cancer. In 2002, Rosemary’s husband was diagnosed with prostate cancer. After two and a half years of caring for him at home, he passed away – leaving behind... Read more

$1.26m in seed funding was awarded in 2018 to help kick-start some of Peter Mac's most innovative new cancer research initiatives. 2018 recipients Dr Kara Britt Cancer ResearhDefining how the stromal microenvironment drives... Read more

Thanks to the generosity of donors to the Foundation’s Permanent Endowment Fund, twenty-four new ground-breaking Peter Mac cancer research projects will be established. In total, $1.3m in seed funding was awarded through... Read more